BIOA:US
$4.52
0.668%
BioAge Labs Inc.News & Events
Last updated: Jun 14, 2025, 5:19 AM ET
BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates
GlobeNewswire JUN 3, 2025 9:00 AM EDTCompany enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody...READ ARTICLEBioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic
GlobeNewswire MAY 29, 2025 9:00 AM EDTIND submission planned for mid-2025 with Phase 1 SAD data anticipated by year end BGE-102...READ ARTICLEBioAge Labs to Present at Upcoming Investor Conferences
GlobeNewswire MAY 27, 2025 4:30 PM EDTEMERYVILLE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", ...READ ARTICLEBIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire MAY 21, 2025 9:00 PM EDTNEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recogniz...READ ARTICLEBioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire MAY 6, 2025 4:30 PM EDTAdvancement of lead candidate BGE-102, an oral, brain-penetrant NLRP3 inhibitor for obesity, with...READ ARTICLENotice to Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra LifeSciences Holdings Corporation (NASDAQ: IART); and Monolithic Power Systems, Inc. (NASDAQ: MPWR): Grabar Law Office Investigates Claims on Your Behalf
GlobeNewswire APR 24, 2025 8:28 AM EDTPHILADELPHIA, April 24, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ...READ ARTICLENotice to Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Monolithic Power Systems, Inc. (NASDAQ: MPWR): Grabar Law Office Investigates Claims on Your Behalf
GlobeNewswire APR 22, 2025 8:13 AM EDTPHILADELPHIA, April 22, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ...READ ARTICLEGrabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); NAPCO Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT)
GlobeNewswire APR 17, 2025 7:31 AM EDTPHILADELPHIA, April 17, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ...READ ARTICLEBioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024
GlobeNewswire MAR 20, 2025 4:30 PM EDTAdvancement of oral, brain-penetrant NLRP3 inhibitor BGE-102, with initial clinical data expected...READ ARTICLEBioArctic receives Orphan Drug Designation for exidavnemab the US
PR Newswire MAR 17, 2025 1:49 PM EDTBioArctic receives Orphan Drug Designation for exidavnemab the US PR Newswire ...READ ARTICLE